Efficacy and Usefulness of DPP4 Inhibitors in NIDDM Patients on the Backdrop of Metformin and Sulfonyl Urea

B. Nivetha, R. Manivannan, G. SureshKumar, G. Aravind, A. Boopal, B. Dhanya mol, S. Divyabharathi, A. Hemalatha
2022 International journal of pharmaceutical sciences review and research  
Diabetes mellitus, sometimes known as diabetes, is a collection of metabolic illnesses defined by a persistently high blood sugar level. Diabetes, if left untreated, can lead to a slew of health issues. Diabetes is caused by either a lack of insulin production by the pancreas or a lack of insulin response by the body's cells. The purpose of the study is to investigate the efficacy of dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors) in individuals with type 2 diabetes mellitus who were
more » ... ing metformin and a sulphonyl urea as a baseline medication.
doi:10.47583/ijpsrr.2022.v74i01.012 fatcat:w33ddczvvngzhab7jth5ctwn3i